Autolus Therapeutics

Autolus Therapeutics

Yahoo Finance • 12 hours ago

Autolus Therapeutics (AUTL) Grants Inducement Awards to New Employees

Autolus Therapeutics plc (NASDAQ:AUTL) is one of the 10 Fastest Growing Tech Penny Stocks to Buy. On July 1, 2026, Autolus Therapeutics plc (NASDAQ:AUTL) announced that the Compensation Committee of its Board of Directors granted stock op... Full story

Yahoo Finance • 22 days ago

Tango Appoints Robert Azelby To Board Of Directors

(RTTNews) - Tango Therapeutics, Inc. (TNGX), a clinical-stage biotechnology company, announced the appointment of Robert Azelby to its Board of Directors. Azelby brings more than 30 years of experience in executive management, commercial... Full story

Yahoo Finance • 27 days ago

Why Autolus Therapeutics (AUTL) Looks Less Speculative as AUCATZYL Revenue Builds

Autolus Therapeutics plc (NASDAQ:AUTL) is one of the small-cap stocks with potential to rise 1000 percent. Unlike many biotech companies that are still waiting for their first approved product, Autolus already has a treatment on the market... Full story

Yahoo Finance • last month

Autolus Therapeutics Receives Prix Galien UK Award

LONDON and GAITHERSBURG, Md., June 12, 2026 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies an... Full story

Yahoo Finance • 2 months ago

Autolus Therapeutics to Present Clinical Data Update at the American Society of Clinical Oncology Annual Meeting 2026

LONDON and GAITHERSBURG, Md., May 21, 2026 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies and... Full story

Yahoo Finance • 2 months ago

European Equities Traded in the US as American Depositary Receipts Little Changed in Thursday Trading

European equities traded in the US as American depositary receipts were tracking marginally lower la PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 2 months ago

European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading

European equities traded in the US as American depositary receipts were trending lower late Tuesday PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story

Yahoo Finance • 2 months ago

Autolus Therapeutics Q1 Earnings Call Highlights

Key Points Interested in Autolus Therapeutics PLC Sponsored ADR? Here are five stocks we like better. Autolus Therapeutics said first-quarter 2026 product revenue rose to $26.2 million, driven by early traction for AUCATZYL in the U.S. an... Full story

Yahoo Finance • 2 months ago

European Equities Traded in the US as American Depositary Receipts Heading Lower in Thursday Trading

European equities traded in the US as American depositary receipts were tracking lower late Thursday PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 3 months ago

European Equities Traded in the US as American Depositary Receipts Decline Tuesday

European equities traded in the US as American depositary receipts were lower on Tuesday morning, do PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 3 months ago

Autolus Therapeutics to Participate in Upcoming Investor Conferences

LONDON and GAITHERSBURG, Md., April 07, 2026 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies,... Full story

Yahoo Finance • 3 months ago

Mizuho Lowers its Price Target on Autolus Therapeutics plc (AUTL) to $10 from $12

Autolus Therapeutics plc (NASDAQ:AUTL) is one of the 7 Fastest Growing European Stocks to Invest In. On March 31, 2026, Mizuho lowered its price target on Autolus Therapeutics plc (NASDAQ:AUTL) to $10 from $12 previously and maintained an... Full story

Yahoo Finance • 4 months ago

European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading

European equities traded in the US as American depositary receipts were little changed late Friday m PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 4 months ago

Pre-Market Earnings Report for March 27, 2026 : CCL, TMC, CUK, KOPN, SBC, AUTL, SNWV, HUMA, SLE

The following companies are expected to report earnings prior to market open on 03/27/2026. Visit our Earnings Calendar for a full list of expected earnings releases. Carnival Corporation (CCL)is reporting for the quarter ending Februa... Full story

Yahoo Finance • 4 months ago

Autolus Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on March 27, 2026

LONDON and GAITHERSBURG, Md., March 16, 2026 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a commercial stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies,... Full story

Yahoo Finance • 5 months ago

Spotlight On Silence Therapeutics And 2 Other Promising Penny Stocks

As February begins, the U.S. stock market is showing strength, with major indexes like the Dow Jones and S&P 500 posting significant gains. In this context of rising indices, investors often look for opportunities that may offer growth pot... Full story

Yahoo Finance • 6 months ago

Needham ups Autolus target, names top pick for 2026

Needham raised the firm’s price target on Autolus Therapeutics (AUTL) to $11 from $10 and keeps a Buy rating on the shares. The firm also names Autolus a top pick for 2026. While Aucatzyl’s launch has been impressive with $76M in sales, in... Full story

Yahoo Finance • 7 months ago

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

European equities traded in the US as American depositary receipts were tracking higher late Tuesday PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 7 months ago

3 Promising Penny Stocks With Market Caps Over $70M

With the recent surge in U.S. stock markets following the Federal Reserve's interest rate cuts, investors are keenly observing how these changes might impact various sectors. While major indices like the S&P 500 and Dow Jones have shown si... Full story

Yahoo Finance • 7 months ago

Autolus Therapeutics Presents Updated Clinical Data from the CARLYSLE Trial in Patients with Severe Refractory Systemic Lupus Erythematosus at the American Society of Hematology (ASH) Annual Meeting 2025

Data show deep, durable responses in the 50 million cell dose level cohort; initial data suggest substantial early improvement in three patients dosed with 100 million cellsAll patients show deep B-cell depletion after infusion, suggesting... Full story